Neuropsychiatric features of systemic lupus erythematosus

被引:69
作者
Borchers, AT
Aoki, CA
Naguwa, SM
Keen, CL
Shoenfeld, Y
Gershwin, ME
机构
[1] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[3] Tel Aviv Univ, Sheba Med Ctr, Dept Med B, Ctr Autoimmune Dis, IL-69978 Tel Aviv, Israel
关键词
neuropsychiatric systemic lupus erythematosus; neuroimaging; cognitive testing; anti-phospholipid syndrome; autoantibodies; cytokines;
D O I
10.1016/j.autrev.2005.01.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious and well known complication of systemic lupus erythematosus that remains a significant source of morbidity and mortality. Fortunately, advances in neuroimaging techniques and cognitive testing have improved the diagnosis of this disease and allowed earlier and more successful therapeutic intervention. Further, the association of NPSLE with the anti-phospholipid syndrome, other autoantibodies and inflammatory cytokines have also provided clues to the diagnosis and pathophysiology. Treatment of NPSLE is largely symptom based with outcome based on appropriate diagnosis. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:329 / 344
页数:16
相关论文
共 100 条
[1]   Neuropsychiatric lupus syndromes -: Relationship with antiphospholipid antibodies [J].
Afeltra, A ;
Garzia, P ;
Mitterhofer, AP ;
Vadacca, M ;
Galluzzo, S ;
Del Porto, F ;
Finamore, L ;
Pascucci, S ;
Gasparini, M ;
Laganà, B ;
Caccavo, D ;
Ferri, GM ;
Amoroso, A ;
Francia, A .
NEUROLOGY, 2003, 61 (01) :108-110
[2]   Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities [J].
Ainiala, H ;
Hietaharju, A ;
Dastidar, P ;
Loukkola, J ;
Lehtimäki, T ;
Peltola, J ;
Korpela, M ;
Heinonen, T ;
Nikkari, ST .
ARTHRITIS AND RHEUMATISM, 2004, 50 (03) :858-865
[3]   The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus [J].
Ainiala, H ;
Loukkola, J ;
Peltola, J ;
Korpela, M ;
Hietaharju, A .
NEUROLOGY, 2001, 57 (03) :496-500
[4]  
Alarcón GS, 2001, ARTHRITIS RHEUM, V44, P2797, DOI 10.1002/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO
[5]  
2-9
[6]   Ribosomal P autoantibodies in systemic lupus erythematosus - Frequencies in different ethnic groups and clinical and immunogenetic associations [J].
Arnett, FC ;
Reveille, JD ;
Moutsopoulos, HM ;
Georgescu, L ;
Elkon, KB .
ARTHRITIS AND RHEUMATISM, 1996, 39 (11) :1833-1839
[7]  
Baca V, 1999, J RHEUMATOL, V26, P432
[8]  
BARILE L, 1992, J RHEUMATOL, V19, P370
[9]  
Bellomio V, 2000, LUPUS, V9, P377
[10]   Survival analysis of 306 European Spanish patients with systemic lupus erythematosus [J].
Blanco, FJ ;
Gomez-Reino, JJ ;
de la Mata, J ;
Corrales, A ;
Rodriguez-Valverde, V ;
Rosas, JC ;
de la Camara, AG ;
Pascual, E .
LUPUS, 1998, 7 (03) :159-163